from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0707/rpsC

LFCtreatmentdescriptionclass of inhibitor

-0.208

Amikacinug/mL Amikacintranslation

-1.027

Cap5-10ug/mL Capreomycintranslation

-1.633

Rox10-50 ug/mL Roxithromycintranslation

0.812

SM2-5 ug/mL Streptomycintranslation

-0.731

Tet5-10 ug/mL Tetracyclinetranslation

0.614

Rif0.2-5ug/mL Rifampicintranscription

0.743

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.050

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.424

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.546

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.348

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.135

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.238

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.501

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.062

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.650

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.517

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.025

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.987

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.361

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.432

KCN5-20 ug/mL Potassium cyaniderespiration

-0.706

NaN30.2-2 mM Sodium aziderespiration

0.358

Nigericin50 uM Nigericinrespiration

-0.207

TRC10-150 ug/mL Triclosanrespiration

-1.179

TRZ10-25 ug/mL Thioridazinerespiration

0.071

Valinomycin0.5-10 uM Valinomycinrespiration

0.347

ZnSO42 mM ZnSO4respiration

-0.110

menadione6-10 ug/mL Menadionerespiration

-0.179

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.542

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.440

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.483

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.882

NRP_1Non-replicating persistence stage 1dosRassociated

0.608

Amp0.2mg/mL AmpicillincellWall

0.833

Cephalexin20-100 ug/mL CephalexincellWall

0.480

Cerulenin0.32-5 ug/mL CerulenincellWall

0.364

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.426

EMB10-20 ug/mL EthambutolcellWall

0.366

Eta12-40 ug/mL EthionamidecellWall

0.691

INH0.2-0.4 ug/mL IsoniazidcellWall

0.531

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.071

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.106

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.361

BZA0.12 mg/mL BenzamidearomaticAmides

0.551

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.690

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.586

H2O24 mM hydrogen peroxideDNAdamaging

0.803

Levo10 ug/mL LevofloxacinDNAdamaging

0.929

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.097

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.722

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.928

UVUV-irradiationDNAdamaging

-1.136

ARP41-4 ug/mL Antitubercular compound ARP4?

0.401

Antimycin12.5-50 ug/mL Antimycin A?

0.277

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.618

PA_110-50 ug/mL Antitubercular compound PA-1?

0.547

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.345

PA8240.2-2 ug/mL PA-824?

-0.977

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.441

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.267

Verapamil50 uM Verapamil?

0.122

mercaptoethanol2 mM 2-Mercaptoethanol?

0.286

methoxatin10-20 ug/mL Methoxatin?